27.14
+0.35(+1.31%)
Currency In USD
| Previous Close | 26.79 |
| Open | 26.59 |
| Day High | 27.61 |
| Day Low | 25.66 |
| 52-Week High | 39.92 |
| 52-Week Low | 18.35 |
| Volume | 484,216 |
| Average Volume | 188,038 |
| Market Cap | 325.56M |
| PE | 36.19 |
| EPS | 0.75 |
| Moving Average 50 Days | 29.74 |
| Moving Average 200 Days | 28.97 |
| Change | 0.35 |
If you invested $1000 in XOMA Royalty Corp. (XOMA) 10 years ago, it would be worth $1,343.56 as of January 14, 2026 at a share price of $27.14. Whereas If you bought $1000 worth of XOMA Royalty Corp. (XOMA) shares 5 years ago, it would be worth $678.84 as of January 14, 2026 at a share price of $27.14.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
XOMA Royalty Announces CFO Transition
GlobeNewswire Inc.
Jan 12, 2026 12:30 PM GMT
EMERYVILLE, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA) announced today its Chief Financial Officer, Thomas Burns, will be stepping down from his position with XOMA Royalty to pursue other prof
XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab
GlobeNewswire Inc.
Dec 30, 2025 12:30 PM GMT
– Takeda regains a majority of XOMA Royalty’s royalty interest in mezagitamab (TAK-079) –– XOMA Royalty will be entitled to payments based on a share of milestones and royalties associated with nine development-stage assets held within Takeda’s exter
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc
GlobeNewswire Inc.
Dec 05, 2025 2:00 PM GMT
EMERYVILLE, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA), the biotech royalty aggregator, today announced it has successfully completed its previously announced acquisition of the entire issued